CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC. et al > Summary
Court Case Number 2:18-cv-14366
Filing Date Sep 27, 2018
Termination Date Feb 8, 2019
Court New Jersey District Court
Status Statistical Closing
JudgesEsther Salas, Michael A. Hammer
Plaintiff
Defendant
Plaintiff Attorneys
16Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Brian Forsatz
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Evangeline L. Shih
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Steven J. Corr
Jones Day
Celgene
Attorney Name: Gabriel P. Brier
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Marta A. Godecki
Quinn Emanuel Urquhart & Sullivan
Defendant Attorneys
7Teva Pharmaceuticals
Attorney Name: Eleonore Ofosu-Antwi
Walsh Pizzi O’Reilly Falanga LLP
Teva Pharmaceuticals
Attorney Name: Liza M. Walsh
Walsh Pizzi O’Reilly Falanga LLP
Teva Pharmaceuticals
Attorney Name: Kristen P. L. Reichenbach
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Jay P. Lefkowitz
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Jeanna M. Wacker
Kirkland & Ellis
Teva Pharmaceuticals
Attorney Name: Mark C. McLennan
Kirkland & Ellis
Counter Defendant
3Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Counter Claimant
Cause
15:1126 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
09993467 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Jun 12, 2018 |